Bariatric Surgery and Semaglutide Affect Bones and Heart Differently in Obese Mice

While both bariatric surgery and semaglutide cause weight loss, they have distinct effects on bone density and heart function in obese mice.

Picoli, Caroline de Carvalho et al.·American journal of physiology. Endocrinology and metabolism·2025·lowAnimal StudyAnimal Study
RPEP-13049Animal Studylow2025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Animal Study
Evidence
low
Sample
N=Not reported (mouse study)
Participants
Obese male mice

What This Study Found

VSG and semaglutide produced comparable weight loss but had divergent effects on bone mineral density and cardiac function in obese mice.

Key Numbers

Obese male mice. 6 weeks semaglutide vs VSG vs sham/saline controls. Comparable weight loss. Different effects on energy expenditure, bone mineral density (microCT), and heart function (echocardiography).

How They Did This

Controlled animal study comparing VSG, semaglutide (6 weeks), and sham/saline controls in obese male mice with micro-CT and indirect calorimetry.

Why This Research Matters

Patients choosing between surgery and GLP-1 drugs need to understand that these approaches may affect bone and heart health differently.

The Bigger Picture

As GLP-1 drugs become alternatives to bariatric surgery, understanding their differing systemic effects is critical for patient selection.

What This Study Doesn't Tell Us

Mouse study — metabolic and physiological responses may differ in humans. Only male mice were studied. Short treatment duration.

Questions This Raises

  • ?Does semaglutide preserve bone density better than bariatric surgery in humans?
  • ?Are the cardiac differences clinically significant in human patients?

Trust & Context

Key Stat:
Distinct effects VSG and semaglutide diverged on skeletal health and heart function despite similar weight loss
Evidence Grade:
Preclinical animal study with controlled design — informative for mechanistic understanding but requires human confirmation.
Study Age:
Published in 2025, addressing a timely question as GLP-1 drugs compete with surgery for obesity treatment.
Original Title:
Vertical sleeve gastrectomy and semaglutide have distinct effects on skeletal health and heart function in obese male mice.
Published In:
American journal of physiology. Endocrinology and metabolism, 328(4), E555-E566 (2025)
Database ID:
RPEP-13049

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Tests effects in animals (usually mice or rats), not humans.

What do these levels mean? →

Frequently Asked Questions

Is semaglutide safer for bones than bariatric surgery?

This mouse study found different bone effects, but human studies are needed to determine which approach better preserves bone health.

Do GLP-1 drugs affect the heart differently than surgery?

In this study, yes — the two approaches showed distinct cardiac effects, though the clinical significance in humans remains unclear.

Read More on RethinkPeptides

Cite This Study

RPEP-13049·https://rethinkpeptides.com/research/RPEP-13049

APA

Picoli, Caroline de Carvalho; Tsibulnikov, Sergey; Ho, Mavy; DeMambro, Victoria; Feng, Tiange; Eltahir, May; Le, Phuong T; Chlebek, Carolyn; Rosen, Clifford J; Ryzhov, Sergey; Li, Ziru. (2025). Vertical sleeve gastrectomy and semaglutide have distinct effects on skeletal health and heart function in obese male mice.. American journal of physiology. Endocrinology and metabolism, 328(4), E555-E566. https://doi.org/10.1152/ajpendo.00521.2024

MLA

Picoli, Caroline de Carvalho, et al. "Vertical sleeve gastrectomy and semaglutide have distinct effects on skeletal health and heart function in obese male mice.." American journal of physiology. Endocrinology and metabolism, 2025. https://doi.org/10.1152/ajpendo.00521.2024

RethinkPeptides

RethinkPeptides Research Database. "Vertical sleeve gastrectomy and semaglutide have distinct ef..." RPEP-13049. Retrieved from https://rethinkpeptides.com/research/picoli-2025-vertical-sleeve-gastrectomy-and

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.